Isabella Zwiener
Ingelheim Am Rhein, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Empagliflozin after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial.
Journal: CJC open
Published: November 20, 2023
Baseline characteristics of patients enrolled in the EMPACT-MI trial.
Journal: European journal of heart failure
Published: May 27, 2023
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
Journal: American heart journal
Published: January 30, 2022
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
Journal: Journal of the American Heart Association
Published: March 23, 2021
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
Journal: Journal of cardiac failure
Published: February 20, 2021
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial.
Journal: JACC. Heart failure
Published: January 15, 2021
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on Asia.
Journal: Diabetes, obesity & metabolism
Published: December 28, 2020
Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial.
Journal: European journal of heart failure
Published: October 05, 2020
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOME.
Journal: Diabetes, obesity & metabolism
Published: September 07, 2020
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.
Journal: Cardiovascular diabetology
Published: August 24, 2020
Last Updated: 09/26/2026